Literature DB >> 6417138

Biosynthesis and maturation of arylsulfatase B in normal and mutant cultured human fibroblasts.

F Steckel, A Hasilik, K von Figura.   

Abstract

The biosynthesis of arylsulfatase B in normal and mutant human skin fibroblasts was studied by metabolic labeling with radioactive amino acids, monosaccharides, or 32Pi and by specific immunoprecipitation followed by polyacrylamide gel electrophoresis and fluorography. Three major polypeptides with apparent molecular weights of 47,000, 40,000, and 31,000 were found intracellularly and one of 64,000 in the medium. Pulse-chase labeling and uptake experiments showed that arylsulfatase B synthesized and secreted as a 64,000 precursor was intracellularly processed within less than 24 h via short lived intermediates to two different forms. Form I (chains of 47,000 and 11,500) was labeled earlier and was about twice as stable as form II (chains of 40,000 and 31,000). The secreted 64,000 precursor and the 40,000 chain of form II contained oligosaccharides resistant to endo-beta-N-acetylglucosaminidase H. In the other chains mainly cleavable and phosphorylated oligosaccharides were found. Arylsulfatase B activity was associated with the 64,000 precursor and with form I, but not with form II. Fibroblasts of four patients with the severe form of mucopolysaccharidosis type VI, which were deficient in arylsulfatase B activity, synthesized and secreted the 64,000 precursor at a normal rate. This precursor, however, had little if any catalytic activity and one of its mature forms (I) was rapidly degraded.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417138

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Trafficking of lysosomal enzymes in normal and disease states.

Authors:  S Kornfeld
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

2.  Animal models for lysosomal storage diseases: a new case of feline mucopolysaccharidosis VI.

Authors:  P Di Natale; T Annella; A Daniele; G Spagnuolo; R Cerundolo; D de Caprariis; A E Gravino
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  Human N-acetylgalactosamine-4-sulphatase biosynthesis and maturation in normal, Maroteaux-Lamy and multiple-sulphatase-deficient fibroblasts.

Authors:  J A Taylor; G J Gibson; D A Brooks; J J Hopwood
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

4.  Site-1 protease-activated formation of lysosomal targeting motifs is independent of the lipogenic transcription control.

Authors:  Sarah Klünder; Jörg Heeren; Sandra Markmann; René Santer; Thomas Braulke; Sandra Pohl
Journal:  J Lipid Res       Date:  2015-06-24       Impact factor: 5.922

5.  Mucopolysaccharidosis type VI: identification of three mutations in the arylsulfatase B gene of patients with the severe and mild phenotypes provides molecular evidence for genetic heterogeneity.

Authors:  W D Jin; C E Jackson; R J Desnick; E H Schuchman
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

Review 6.  Review: the immunochemical analysis of enzyme from mucopolysaccharidoses patients.

Authors:  D A Brooks
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

7.  Human liver N-acetylglucosamine-6-sulphate sulphatase. Purification and characterization.

Authors:  C Freeman; P R Clements; J J Hopwood
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

8.  Cell-surface arylsulfatase A and B on sinusoidal endothelial cells, hepatocytes, and Kupffer cells in mammalian livers.

Authors:  Keiko Mitsunaga-Nakatsubo; Shinichiro Kusunoki; Hayato Kawakami; Koji Akasaka; Yoshihiro Akimoto
Journal:  Med Mol Morphol       Date:  2009-06-18       Impact factor: 2.309

9.  Subcellular distribution of acid alpha-glucosidase in fibroblasts and of antigenically cross-reactive material in Pompe's disease fibroblasts.

Authors:  T Iwamasa; K Nashiro; T Ohshita; I Matsuda
Journal:  Histochem J       Date:  1986 Nov-Dec

10.  Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase.

Authors:  D S Anson; J A Taylor; J Bielicki; G S Harper; C Peters; G J Gibson; J J Hopwood
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.